Reversal of in vitro drug induced myeloid suppression by lithium

A. M. Miller, A. A. Yunis

Research output: Contribution to journalArticlepeer-review


We have investigated the ability of lithium to protect against chloramphenicol (CAP) and chlorpromazine (CPZ) induced suppression of human myeloid colony forming cells (CFU(C)). In the standard semi-solid agar assay for human CFU(C) lithium (0.5-10 x 10-3 M) enhances myeloid colony formation by 30-40% and protects against CAP and CPZ induced suppression, in a manner similar to increasing CSF concentrations. Prior depletion of adherent cell populations from human marrow eliminates the lithium effects, thus suggesting a primary action through CSF production.

Original languageEnglish (US)
Pages (from-to)775-780
Number of pages6
JournalExperimental Hematology
Issue number7
StatePublished - 1981
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research


Dive into the research topics of 'Reversal of in vitro drug induced myeloid suppression by lithium'. Together they form a unique fingerprint.

Cite this